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Tumor-associated myeloid cells play a critical role in
supporting tumor progression and metastasis. However,
molecular mechanisms by which tumor cells interact
with myeloid cells to modify therapeutic responses to
anticancer treatments remain largely unknown. We
identified several key factors affecting antitumor effects
of chemotherapy by manipulating the modes of interac-
tion between tumor cells and myeloid cells within
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Figure 1 Cross-talk between tumors and myeloid cells suppresses antitumor effect of chemotherapy.
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tumor microenvironments. Tumor-derived factors such
as VEGF-A and arginase-I upregulate TIM-3 on dendri-
tic cells. TIM-3 interacts with HMGB1 released from
chemotherapy-treated tumor cells, and suppresses innate
pattern recognition signals mediated by nucleic acids
from dying tumor cells. The inhibition of TIM-3 aug-
ments antitumor effects of cytotoxic chemotherapy
against established tumors. Moreover, danger-associated
molecular patterns (DAMPs) released from chemother-
apy-damaged tumor cells induced TIM-4 on TAMs
recruited from bone marrow-derived precursors. TIM-4
directly interacted with AMPK-a1 at phagosome and
activated autophagy-mediated lysosomal degradation of
ingested tumors, leading to reduced antigen presentation
and impaired CTL responses. Consistently, blockade of
the TIM-4/AMPK-a1/ autophagy pathway augmented
antitumor effect of chemotherapeutics by enhancing
tumor-specific CTL responses. Taken together, our find-
ings provide new evidences that targeting of key factors
regulating interplay between tumor cells and myeloid
cells provides new therapeutic strategy to eradicate che-
moresistant tumors.
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